Imugene will forge ahead with a planned pivotal US trial for its blood cancer therapy Azer-cel, having recorded more ‘complete responses’ in its phase 1b study.

What the ceasefire means for global oil markets 🌍🛢️⛽
08:25

Money News with Scott Haywood 💵📊📻 - Thursday, 9th April
37:24

Dirk Mulder - The founder of The Koala News 🐨📰
06:42